−1.751SEK
−30.82 MSEK
155.00 KSEK
About 2CUREX AB
Sector
Industry
CEO
Kenneth Graabek Johansen
Website
Headquarters
Copenhagen
Founded
2006
ISIN
SE0010468124
FIGI
BBG00HYXTR29
2cureX AB engages in the research and development of anti-cancer treatments. It offers IndiTreat, which is a tool that determines treatment methods on individual colorectal cancer patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Copenhagen, Denmark.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 2CUREX is 0.424 SEK — it has decreased by 3.42% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange 2CUREX AB stocks are traded under the ticker 2CUREX.
2CUREX stock is 3.54% volatile and has beta coefficient of −0.16. Check out the list of the most volatile stocks — is 2CUREX AB there?
Yes, you can track 2CUREX AB financials in yearly and quarterly reports right on TradingView.
2CUREX stock has risen by 1.44% compared to the previous week, the month change is a 5.74% rise, over the last year 2CUREX AB has showed a 93.61% decrease.
2CUREX net income for the last quarter is −4.93 M SEK, while the quarter before that showed −10.16 M SEK of net income which accounts for 51.54% change. Track more 2CUREX AB financial stats to get the full picture.
Today 2CUREX AB has the market capitalization of 7.46 M, it has increased by 34.41% over the last week.
No, 2CUREX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 2CUREX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade 2CUREX AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So 2CUREX AB technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating 2CUREX AB stock shows the sell signal. See more of 2CUREX AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. 2CUREX AB EBITDA is −37.16 M SEK, and current EBITDA margin is −23.98 K%. See more stats in 2CUREX AB financial statements.